A share price of SELLAS Life Sciences Group Inc [SLS] is currently trading at $1.56, down -3.11%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The SLS shares have gain 1.30% over the last week, with a monthly amount drifted -4.29%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
SELLAS Life Sciences Group Inc [NASDAQ: SLS] stock has seen the most recent analyst activity on July 21, 2021, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $18. On April 02, 2018, H.C. Wainwright initiated with a Buy rating and assigned a price target of $11 on the stock. Maxim Group upgraded its rating to a Buy but stick to its price target of $13 on March 19, 2018.
SELLAS Life Sciences Group Inc experienced fluctuations in its stock price throughout the past year between $0.77 and $2.12. Currently, Wall Street analysts expect the stock to reach $2.8 within the next 12 months. SELLAS Life Sciences Group Inc [NASDAQ: SLS] shares were valued at $1.56 at the most recent close of the market. An investor can expect a potential return of 79.49% based on the average SLS price forecast.
Analyzing the SLS fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.78, Equity is -1.94 and Total Capital is -1.0. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.5133 points at the first support level, and at 1.4667 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.6133, and for the 2nd resistance point, it is at 1.6667.
Ratios To Look Out For
To put it in perspective, the Current Ratio for SELLAS Life Sciences Group Inc [NASDAQ:SLS] is 4.64. Also, the Quick Ratio is 4.64, while the Cash Ratio stands at 4.14.
Transactions by insiders
Recent insider trading involved VAN NOSTRAND ROBERT L, Director, that happened on Jun 12 ’25 when 10000.0 shares were purchased. Director, Wasman Jane completed a deal on May 30 ’25 to buy 20000.0 shares. Meanwhile, Director Kalin Katherine Bach bought 20000.0 shares on May 22 ’25.
